Search

Deborah L Dragoon

from Altona, NY
Age ~61
Get Report
Also known as:
Deborah L Jaquis
Phone and address:
2032 Miner Farm Rd, Altona, NY 12910
(518) 493-3120
Related to:
Scott S Dragoon, 62Debbie Dragoon, 57
Connected to:
David W Dragoone, 60Jillann M Dragoone, 56Michelle E Dragoon, 67Nora J Dragoone, 32Patrick C Dragoon, 36Alin Dragos, 61Barbara D Dragos, 78Estera Dragos, 47Ion Dragos, 49Kelly B Dragos, 61

Deborah Dragoon Phones & Addresses

  • 2032 Miner Farm Rd, Altona, NY 12910 (518) 493-3120
  • Chazy, NY

Work

Company: Fujitsu Feb 2014 to Mar 2017 Position: Compliance manager

Education

Degree: Bachelors, Bachelor of Science School / High School: St. Lawrence University 1982 to 1986 Specialities: Biology

Skills

Fda • Quality Assurance • Pharmaceutical Industry • Sop • Glp • Validation • Auditing • 21 Cfr Part 11 • Laboratory • Gmp • Software Documentation • Capa • Regulatory Requirements • Computer System Validation • Lifesciences • Cro • Quality System • Regulatory Submissions • Standard Operating Procedure • Quality Auditing • Hplc • Technical Writing • Lims • V&V • Life Sciences • Document Management • Iso 14001 • Iso 9000 • Good Laboratory Practice • Web Development • U.s. Food and Drug Administration • Gxp

Interests

Poverty Alleviation

Industries

Pharmaceuticals

Resumes

Resumes

Deborah Dragoon Photo 1

Quality Control Manager

View page
Location:
Saranac Lake, NY
Industry:
Pharmaceuticals
Work:
Fujitsu Feb 2014 - Mar 2017
Compliance Manager
Medisca Feb 2014 - Mar 2017
Quality Control Manager
Cgi Feb 2011 - Feb 2014
Assistant Processing Supervisor
Pfizer Feb 2005 - Jul 2010
Senior Audit Manager I
Pfizer 1992 - 2005
Various Audit Titles
Education:
St. Lawrence University 1982 - 1986
Bachelors, Bachelor of Science, Biology
Skills:
Fda
Quality Assurance
Pharmaceutical Industry
Sop
Glp
Validation
Auditing
21 Cfr Part 11
Laboratory
Gmp
Software Documentation
Capa
Regulatory Requirements
Computer System Validation
Lifesciences
Cro
Quality System
Regulatory Submissions
Standard Operating Procedure
Quality Auditing
Hplc
Technical Writing
Lims
V&V
Life Sciences
Document Management
Iso 14001
Iso 9000
Good Laboratory Practice
Web Development
U.s. Food and Drug Administration
Gxp
Interests:
Poverty Alleviation

Publications

Us Patents

Implantable Shunt Or Catheter Enabling Gradual Delivery Of Therapeutic Agents

View page
US Patent:
20110060265, Mar 10, 2011
Filed:
Nov 18, 2010
Appl. No.:
12/949032
Inventors:
Deborah L. Dragoon - Altona NY, US
Jonathan Marc Cohen - Monroe NY, US
Assignee:
Wyeth LLC - Madison NJ
International Classification:
A61M 1/00
US Classification:
604 9, 604 8
Abstract:
An implantable catheter or shunt for draining fluid from a body cavity. The catheter or shunt body has a wall structure that carries one or more therapeutic agents in a manner enabling release of the therapeutic agent from the wall structure in situ after surgical implantation of the catheter or shunt body. The therapeutic agent can be gradually released over time to prevent infection, inhibit tissue ingrowths, and/or provide some other desired medicinal purpose. As an example, the therapeutic agent can be rapamycin or an mTOR inhibitor. According to some contemplated embodiments of the present invention, the therapeutic agent carried by the catheter/shunt is rechargeable or refillable in situ so that the therapeutic agent can be gradually released from the catheter/shunt over the expected useful life of the catheter/shunt.

Implantable Shunt Or Catheter Enabling Gradual Delivery Of Therapeutic Agents

View page
US Patent:
20080051691, Feb 28, 2008
Filed:
Aug 27, 2007
Appl. No.:
11/895770
Inventors:
Deborah L. Dragoon - Altona NY, US
Jonathan Marc Cohen - Monroe NY, US
Assignee:
Wyeth - Madison NJ
International Classification:
A61M 27/00
A61K 31/436
A61P 25/00
A61K 9/00
US Classification:
604 8, 424423, 514291
Abstract:
An implantable catheter or shunt for draining fluid from a body cavity. The catheter or shunt body has a wall structure that carries one or more therapeutic agents in a manner enabling release of the therapeutic agent from the wall structure in situ after surgical implantation of the catheter or shunt body. The therapeutic agent can be gradually released over time to prevent infection, inhibit tissue ingrowths, and/or provide some other desired medicinal purpose. As an example, the therapeutic agent can be rapamycin or an mTOR inhibitor. According to some contemplated embodiments of the present invention, the therapeutic agent carried by the catheter/shunt is rechargeable or refillable in situ so that the therapeutic agent can be gradually released from the catheter/shunt over the expected useful life of the catheter/shunt.
Control profile
Deborah L Dragoon from Altona, NY, age ~61 Get Report